Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Anders Krifors"'
Publikováno v:
Intensive Care Medicine Experimental, Vol 11, Iss 1, Pp 1-16 (2023)
Abstract Background Invasive candidiasis (IC) is a severe and often fatal fungal infection that affects critically ill patients. The development of animal models that mimic human disease is essential for advancing our understanding of IC pathophysiol
Externí odkaz:
https://doaj.org/article/b25da35f0a2d49c5ba7b1ca24bd63ed3
Autor:
Peter Ueda, Johan Hansson, Johan Ljungberg, Anders Krifors, Björn Johansson, Martin Larsson, Per Tornhammar, Daniel Peter Andersson, Daniel Brodin, Eli Westerlund, Simon Athlin, Sandra Wojt, Olof Elvstam, Anca Neumann, Arsim Elshani, Julia Giesecke, Jens Edvardsson-Källkvist, Sayam Bunpuckdee, Christian Unge, Jonas Lindell, Ola Blennow
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Objective To assess the efficacy of inhaled ciclesonide in reducing the duration of oxygen therapy (an indicator of time to clinical improvement) among adults hospitalised with COVID-19.Design Multicentre, randomised, controlled, open-label trial.Set
Externí odkaz:
https://doaj.org/article/ecbb55d78bfd47bcb49516dc59bdb8f8
Publikováno v:
BMJ Open Ophthalmology, Vol 6, Iss 1 (2021)
Background COVID-19 is caused by SARS-CoV-2. Virus has been found in conjunctiva of hospitalised patients with COVID-19. Conjunctivitis has also been reported as a presenting symptom of disease.Objective The aims of the study were to investigate the
Externí odkaz:
https://doaj.org/article/03efa35de1344e6d99bb73973ec88649
Autor:
Anders Krifors, Måns Ullberg, Markus Castegren, Johan Petersson, Ernesto Sparrelid, Volkan Özenci, Ola Blennow
Publikováno v:
Journal of Fungi, Vol 8, Iss 8, p 832 (2022)
The T2Bacteria panel is a direct-from-blood assay that delivers rapid results, targeting E. coli, S. aureus, K. pneumoniae, A. baumanii, P. aeruginosa, and E. faecium (ESKAPE pathogens). In this study, T2Bacteria and T2Candida (targeting C. albicans/
Externí odkaz:
https://doaj.org/article/2e6ad52b08be47d296bee3a5802b1b82
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240753 (2020)
BackgroundImmune system suppression during critical care contributes to the risk of acquired bacterial infections with Pseudomonas (P.) aeruginosa. Repeated exposure to endotoxin can attenuate systemic inflammatory cytokine responses. Mechanical vent
Externí odkaz:
https://doaj.org/article/00c8f166fbc9415eac2b680baa48d316
Autor:
Anders Krifors, Måns Ullberg, Markus Castegren, Johan Petersson, Ernesto Sparrelid, Helena Hammarström, Jan Sjölin, Volkan Özenci, Ola Blennow
Publikováno v:
Journal of Fungi, Vol 8, Iss 1, p 86 (2022)
The T2Candida magnetic resonance assay is a direct-from-blood pathogen detection assay that delivers a result within 3–5 h, targeting the most clinically relevant Candida species. Between February 2019 and March 2021, the study included consecutive
Externí odkaz:
https://doaj.org/article/0dea03a62bec4e2d9d3e088ec6c26fe1
Autor:
Anders Krifors, Elisabeth Freyhult, Mulki Rashid Teljebäck, Robert P. A. Wallin, Ola Winqvist, Emeli Månsson
Publikováno v:
Infectious Diseases. 55:142-148
Background: Vaccination against SARS-CoV-2 reduces the risk of hospitalisation and death, but vaccine-induced IgG antibodies against the spike protein (IgG S) decline over time. Less is known about the nature of the vaccine-induced T-cell response to
Autor:
Anders Krifors, Volkan Özenci, Måns Ullberg, Malin Ackefors, Martin Jädersten, Kristoffer Strålin, Ola Blennow
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212812 (2019)
Invasive mold infections are life-threatening complications in patients with hematological malignancies. Conventional microbiological methods for diagnosing invasive pulmonary mold infections have low sensitivity, and molecular methods are being deve
Externí odkaz:
https://doaj.org/article/d74442320ea6453aa967756f6b2804d0
Autor:
Daniel Brodin, Per Tornhammar, Peter Ueda, Anders Krifors, Eli Westerlund, Simon Athlin, Sandra Wojt, Olof Elvstam, Anca Neumann, Arsim Elshani, Julia Giesecke, Jens Edvardsson-Källkvist, Sayam Bunpuckdee, Christian Unge, Martin Larsson, Björn Johansson, Johan Ljungberg, Jonas Lindell, Johan Hansson, Ola Blennow, Daniel Peter Andersson
ObjectiveTo assess the efficacy of inhaled ciclesonide in reducing the duration of oxygen therapy (an indicator of time to clinical improvement) among adults hospitalised with COVID-19.DesignMulticentre, randomised, controlled, open-label trial.Setti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::643e8a335d0a57192ac1c82a333fec0e
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-501168
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-501168
Autor:
Helena Hammarström, Anders Krifors, Simon Athlin, Vanda Friman, Karan Golestani, Anita Hällgren, Gisela Otto, Sara Oweling, Karlis Pauksens, Amelie Kinch, Ola Blennow
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background Recent studies have reported that reduced-dose trimethoprim-sulfamethoxazole (TMP-SMX) may be effective in the treatment of Pneumocystis jirovecii pneumonia (PJP), but data are lacking for patients with hematologic malignancies. Methods Th